Staying current on the latest treatment guidelines, medical safety updates, reimbursement considerations and other topics isn’t easy. While publications and specialty journals play an important role, Skipta News can be a more efficient and, at times, more effective way to stay informed. News content for each Skipta community is curated by specialty, ensuring it’s relevant for those in that specialty and network of peers. It enables instant feedback and discussion: A member who posts an article or news story might explain why they think the article is important and people will comment on that. What’s more, when new clinical guidelines are released, through the platform, active members rely on Skipta-enabled communications with fellow clinicians to understand the challenges of implementation.
News is available as it happens. Unlike some industry publications, Skipta’s frequent posts are up-to-date and include advance looks at what’s coming, which can help inform a treatment plan. “Say you have a case that is not responding well or is not tolerant to the current guidelines,” says Meijer pharmacist Alan Tanabe. “Reading a relevant article on other treatment options could prompt a discussion with the provider or physician about whether the alternative could be an option for that patient.” Tanabe also appreciates the ability to follow selected cases, articles, and topics and members, “so I get an alert whenever someone posts or comments on something I’ve chosen to follow.”